1. Home
  2. OUST vs HAE Comparison

OUST vs HAE Comparison

Compare OUST & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ouster Inc.

OUST

Ouster Inc.

HOLD

Current Price

$38.39

Market Cap

2.9B

Sector

Technology

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$78.80

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OUST
HAE
Founded
2015
1971
Country
United States
United States
Employees
320
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.8B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
OUST
HAE
Price
$38.39
$78.80
Analyst Decision
Strong Buy
Buy
Analyst Count
4
9
Target Price
$39.25
$84.13
AVG Volume (30 Days)
5.4M
930.6K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.05
Revenue
N/A
$910,373,000.00
Revenue This Year
$33.20
N/A
Revenue Next Year
$37.27
$5.23
P/E Ratio
N/A
$38.40
Revenue Growth
N/A
N/A
52 Week Low
$16.40
$47.32
52 Week High
$49.39
$87.32

Technical Indicators

Market Signals
Indicator
OUST
HAE
Relative Strength Index (RSI) 52.95 80.04
Support Level $26.62 $48.98
Resistance Level $39.17 $86.72
Average True Range (ATR) 5.00 2.89
MACD -0.77 1.46
Stochastic Oscillator 42.80 89.95

Price Performance

Historical Comparison
OUST
HAE

About OUST Ouster Inc.

Ouster Inc is a provider of lidar sensors for the automotive, industrial, robotics, and smart infrastructure industries. Ouster's products include high-resolution scanning and solid-state digital lidar sensors, Velodyne Lidar sensors, and software solutions. The company operates in the Americas, Asia and the Pacific, Europe, the Middle East, and Africa. It derives maximum revenue from the Americas. The Company operates as one reportable and operating segment, which relates to the sale and production of lidar sensor kits.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: